Using sera of 26 double-blind placebo-controlled food-challenge-proven fish-allergic patients , reduction in allergenic activity ranged from 10 - to 5,000-fold ( 1,000-fold on average ) , but with retained immunogenicity ( immunization in mice/rabbits ) and potency to stimulate human PBMCs .